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Sequence Analysis Reveals Extensive Polymorphism and Evidence of Deletions within the 
E2 Glycoprotein Gene of Several Strains of Murine Hepatitis Virus 
SUEZANNE E. PARKER, THOMAS M. GALLAGHER, AND MICHAEL J. BUCHMEIER’ 
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037 
Received June 13, 1989; accepted August 25, 1989 
Direct RNA sequence analysis of the E2 gene of wild-type MHV4 and of neutralization resistant, neuroattenuated 
variants has identified a polymorphic region with respect to deletions. These variants had large deletions of 142 to 159 
amino acids mapping to a localized region in the amino-terminal domain of the peplomer glycoprotein. The nucleotide 
sequence of the E2 gene for wild-type strain MHV-4 was found to be very similar to that of MHV-JHM but had an 
insertion of 423 nucleotides resulting in the addition of a stretch of 141 unique amino acids in the amino-terminal 
domain of E2. We propose that deletions reflect a major source of heterogeneity in the E2 protein of MHV. o 198s 
Academic Press, Inc. 
INTRODUCTION 
Mouse hepatitis virus type 4 (MHV-4, strain JHM) is 
a neurotropic member of the Coronaviridae (Weiner, 
1973; Lampert et a/., 1973; Haspel et a/., 1978; Wege 
et a/., 1982). The virus causes acute, subacute, and 
chronic infections of the CNS in mice and rats with 
symptoms ranging from a fatal encephalitis to a 
chronic demyelinating disease. lntracerebral inocula- 
tion of wild-type MHV-4 in susceptible mice usually re- 
sults in a fatal encephalomyelitis characterized by 
widespread destruction of CNS neurons with accom- 
panying demyelination. Recovery from the acute infec- 
tion is rare, and the few mice that survive develop a 
central nervous system disease characterized by focal 
demyelinating lesions followed by remyelination (Kno- 
bler et a/., 1982; Lampert et a/., 1973). The demyelin- 
ation has been attributed to virus infection and destruc- 
tion of oligodendrocytes (Lampert et al., 1973; Haspel 
et a/., 1978; Dubois-Dalcq et a/., 1982). 
Neuroattenuated variants of MHV-4 developed in 
this laboratory and others offer a model system for the 
study of the pathogenesis of MHV infections. The fatal 
encephalitis usually associated with wild-type MHV-4 
is not seen following infection with ts mutants (Haspel 
eta/., 1978) spontaneously arising mutants (Stohlman 
et a/., 1982) or variants selected on the basis of resis- 
tance to neutralization by monoclonal antibodies (MAb) 
against the E2 glycoprotein of the virus (Dalziel et al., 
1986; Fleming et a/., 1986; Wege et al., 1988). Infec- 
tion of susceptible mice with these variants results in 
chronic demyelinating disease with episodes of remy- 
’ To whom requests for reprints should be addressed at IMM5. 
elination and demyelination with little neuronal involve- 
ment. 
Characterization of the genetic alteration(s) respon- 
sible for the neuroattenuation would map the determi- 
nants which contribute to the neurovirulence of a MHV- 
4 infection. In the case of ts mutants, it would be diffi- 
cult to localize these changes as the attenuated virus 
may contain multiple mutations which may or may not 
contribute to the attenuated phenotype. Variants that 
have escaped neutralization by MAbs directed against 
the peplomer glycoprotein (E2) offer an advantage for 
mapping of neurovirulence because mutations in E2 
are specifically selected. We have previously reported 
the isolation and characterization of two such groups 
of variants selected for the ability to resist neutraliza- 
tion by MAb directed against epitopes E2B (MAb 
5A13.5) and E2C (MAb 4811.6) respectively. In con- 
trast to the fatal encephalitis induced by the wild-type 
MHV-4, both variants were found to be attenuated and 
caused chronic demyelinating disease with demyelin- 
ation and remyelination occurring up to 65 days postin- 
fection (Dalziel et a/., 1986). 
E2 is initially synthesized as a large 180-kDa periph- 
eral membrane glycoprotein (Siddel et a/., 1982) which 
is post-translationally cleaved. Cleavage yields two 
nonidentical subunits of approximately 90 kDa (Stur- 
man et al., 1985) consisting of an amino-terminal do- 
main (S, in the terminology of Cavanagh (1983) or 90B 
in the terminology of Sturman et al. (1985)) and a car- 
boxy-terminal domain (S, or 90A). To map these E2 mu- 
tations we have sequenced the E2 genes of wild-type 
and antibody-resistant variants. We have found by di- 
rect RNA sequencing that the MAb-resistant variants 
of MHV-4 have large deletions in the 5’ coding region 
0042-6822189 $3.00 
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of the E2 gene. The deletions we describe result in a 
loss of 142 to 159 amino acids localized to the amino- 
terminal domain (S, or 90B) of the E2 protein. In con- 
trast, the carboxy-terminal domain was found to be 
largely conserved. 
MATERIALS AND METHODS 
Virus and cells 
MHV-4 was originally obtained from L. P. Weiner and 
is routinely propagated on SAC- cells as previously de- 
scribed for MHV-A59 (Sturman et al., 1980). A working 
stock of MHV4 for RNA sequence analysis was pre- 
pared by minimal amplification of an isolate plaque pu- 
rified in 1986. SAC- cells were grown to confluency in 
175cm2 flasks in Dulbecco’s modified Eagle’s me- 
dium (DMEM) supplemented with 8.5% heat-inacti- 
vated calf serum. Cells were inoculated with 0.01 to 
0.1 PFU per cell and after a one-hour adsorption at 37” 
the inoculum was removed and replaced with growth 
medium. Virus was harvested when signs of cytopathic 
effect were evident (75-900~ syncytium formation; 16- 
18 hr postinfection) by three cycles of freeze-thawing 
(-70”) followed by a low-speed centrifugation at 300 
g to remove cellular debris. 
Isolation and characterization of antibody-resistant 
variants V5A13.1 and V4Bl 1.3 have been previously 
described (Dalziel et al., 1986). For purposes of identi- 
fication these will be referred to hereafter as V5A13.1(86) 
and V4Bl 1.3(86). Briefly, a plaque-purified stock of 
MHV-4 (1986) was subjected to two rounds of neutral- 
ization with MAb 5A13.5 or 4B11.6. Virus that escaped 
neutralization was plaque purified two times. Working 
stocks of variant virus for RNA sequence analysis were 
prepared from plaque-purified stocks by propagation 
on SAC- cells and screened for maintenance of the 
antibody-resistant phenotype (Dalziel et al., 1986). A 
second variant, V5A13(88), was selected with MAb 
5A13.5 from a stock of MHV-4 that had been passaged 
several times in vitro. A working stock of V5A13(88) 
was prepared for RNA sequence analysis by propaga- 
tion on SAC- cells as described. This virus was not sub- 
sequently plaque purified, thus the RNA sequence of 
this variant reflects the consensus sequence of the 
population of antibody-resistant virus. A derivative of 
MHV-JHM maintained in Japan, JHM-X (Makino et a/., 
1984) was kindly provided by Dr. M. M. C. Lai (Univer- 
sity of Southern California). 
RNA sequence analysis 
Total infected cytoplasmic RNA was prepared by the 
guanidine isothiocyanate (GTC) extraction method of 
Chirgwin et al. (1979) from SAC- infected cells. Etha- 
nol-precipitated RNA was used directly for sequence 
analysis. The viral RNA sequence was determined by 
a modification of the dideoxy primer extension method 
of Hamlyn eta/. (1981). 
Initially, synthetic oligonucleotide primers of 20 
bases complementary to the cDNA sequence of MHV- 
JHM mRNA 3 (Schmidt et al., 1987) were synthesized 
on an Applied Biosystems 380-A oligonucleotide 
synthesizer and purified by electrophoresis on 169’0 
acrylamide, 8 M urea, TBE [0.089 MTris-HCI (pH 8.3) 
0.089 1\/1 boric acid, 0.002 M EDTA] sequencing gels 
(Sanger et al., 1977). As sequence was obtained for 
the E2 of MHV-4, oligonucleotide primers were made 
which were complementary to the 5’end of the extend- 
ing MHV-4 E2 sequence. Oligonucleotide primers 
were end labeled by incubating 50 pM of purified 
primer with 0.5 mCi of [T-~~P]ATP (7000 CilmM, ICN 
Radiochemicals) and 3 U of T4 polynucleotide kinase 
(Promega) in a final volume of 8 ~1 of kinase buffer [50 
mMTris-HCI (pH 7.5) 10 mM MgC12, 5 mM DTT, 0.1 
mM spermidine, 0.1 mM EDTA] for 30 min at 37”. Ra- 
diolabeled primers were extracted with phenol/chloro- 
form, ethanol precipitated, and resuspended in water 
at a concentration of approximately 5.0 X 1 O3 cpmlpM 
(3.0 X 1 O5 cpm/pl). Template RNA (75-l 00 pg in water) 
was added to 3.5 p.M of radiolabeled primer in a final 
volume of 12.5 ~1 of annealing buffer [50 mM Tris-HCI 
(pH 8.3) 60 mM NaCI, 10 mM DTT, 1 mM EDTA] and 
incubated for 3 min at 90”, followed by 10 min at 65“, 
then for 20 min at 45”. The resulting hybrids (2 ~1) were 
added to four separate sequencing reactions each 
containing all four deoxynucleotides (0.22 mM in each 
dNTP), the appropriate dideoxynucleotide (0.04 mM), 
and reverse transcriptase (1 U, AMV Life Sciences) in a 
final volume of 6 ~1 of reverse transcriptase buffer [50 
mMTris-HCI (pH 8.3) 50 mM KCI, 10 mll/l MgC12]. Se- 
quencing reaction mixtures were incubated for 30 min 
at 45” and then 2 ~1 of a deoxynucleotide chase mix 
(0.1 mM in each dNTP and 0.5 U reverse transcriptase 
in reverse transcriptase buffer) was added to each re- 
action and incubation was continued for an additional 
15 min at 45”. Dye mixture (10 mlLI EDTA, 0.1% brom- 
phenol blue, and 0.1 Yo xylene cyanol FF in deionized 
formamide) was added to each reaction, and the sam- 
ples were heated for 5 min at 100’. The reaction mix- 
ture (3-4 ~1) was loaded onto each lane of a sequenc- 
ing gel (6% polyacrylamide, 7 11/1 urea in TBE, 48.5 x 20 
X 0.4 mm) @anger et a/., 1977) and the samples were 
electrophoresed at 40 W for 2.5-3.5 hr. Gels were fixed 
for 15 min by immersion in 10% acetic acid and 10% 
methanol, dried, and subsequently autoradiographed 
on Kodak XAR or XRP film. By this method it was possi- 
ble to sequence 100-l 50 nucleotide bases per oligo- 
nucleotide primer. Sequence data were compiled and 
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analyzed using the University of Wisconsin Genetics 
Computer Group Sequence Analysis software package 
(Devereux et a/., 1984). 
RESULTS 
Sequence of the MHV-4 E2 gene 
The cDNA sequence of the E2 gene of MHV-JHM 
(Schmidt et al., 1987) was used as a starting point to 
design synthetic oligonucleotides at 150-base inter- 
vals which served as primers for the direct dideoxy se- 
quence analysis of viral RNA. From primer extension 
analysis 4149 nucleotides were sequenced compris- 
ing a single open reading frame (ORF) of 4131 nucleo- 
tides with the potential to encode a protein of 1376 
amino acids (Fig. 1). The sequence starts with the 5’ 
TAATCTAAAC intergenic homology sequence and is 
immediately followed by the initiation codon. A similar 
intergenic sequence has been found to precede the 5’ 
initiation codons of several MHV RNAs (Skinner et a/., 
1985; Skinner and Siddel, 1985) including the E2 gene 
of MHV-JHM (Schmidt et al., 1987) and MHV-A59 
(Luytjes et al., 1987). The nucleotide sequence of the 
E2 gene for MHV-4 revealed one major difference from 
the sequence previously reported for MHV-JHM 
(Schmidt et al,, 1987). In the MHV-4 gene, there is an 
insertion of 423 nucleotides relative to MHV-JHM start- 
ing at position 1359 and extending through to nucleo- 
tide 1781. The inserted nucleotide sequence poten- 
tially encodes 141 unique residues starting at amino 
acid 454 in the amino-terminal domain of E2. The MHV- 
4 E2 gene contains 6 additional nucleotide substitu- 
tions that result in 4 amino acid differences in the pre- 
dicted sequence of the E2 protein as compared to 
MHV-JHM (Fig. 1). There is also a lysine to asparagine 
substitution at amino acid 453 in the E2 gene of MHV- 
4 at the 5’junction of the MHV-4 insertion. 
Sequence analysis of the E2 gene of MHV-4 variants 
Direct RNA sequencing of the viral RNA encoding 
the E2 gene of V5A13.1(86) and V4811.3(86) demon- 
strated that both variants had large deletions localized 
within the 5’ half of the gene (Fig. 2). The sequence of 
the entire E2 gene of V5A13.1(86) was determined and 
a large deletion of 426 nucleotides starting at nucleo- 
tide 1298 and extending through to nucleotide 1723 of 
AND BUCHMEIER 
the parental MHV-4 was found. This sequence pre- 
dicts a truncated E2 protein containing 1234 amino 
acids compared with the 1376 amino acids as was 
found in MHV-4. The deleted domain corresponds to 
amino acids 434-575 in the amino-terminal half of the 
protein. In addition, as a consequence of the deletion, 
a lysine + asparagine substitution occurred at position 
433 (the 5’ boundary of the deletion) in the variant E2. 
Having localized a deletion in V5A13.1(86) to the ami- 
no-terminal half of E2, the coding region for this domain 
(nucleotides l-2333) was subsequently sequenced for 
V4B11.3(86). This E2 gene was found to have deleted 
nucleotides 1285 through 1761 of the MHV-4 parental 
sequence which results in an ORF with the potential to 
encode 12 17 amino acids representing a loss of resi- 
dues 429-586 relative to wild-type. V4B11.3(86) also 
had a glutamine + lysine substitution at amino acid 
404 as a result of a single base substitution in the 
V4B11.3(86) gene. However, this substitution was 
found in only one of three 481 1.6 variants which were 
sequenced in this region and thus does not correlate 
with resistance to neutralization. 
Given that the deletions in two of the variants were 
found to localize to a specific region in the 5’ portion of 
the gene, we concentrated subsequent analysis in this 
region. The RNA from eight additional V5A13(86) vari- 
ants and 12 additional V4Bl l(86) variants was se- 
quenced from nucleotides 1228 through 1788 (relative 
to the MHV-4 sequence). All of the variants selected in 
1986 by MAb 5A13.5 were found to contain the identi- 
cal 426-nucleotide deletion found in V5A13.1(86), and 
all 1986 4B11.6 variants were found to contain the 
identical 477-nucleotide deletion found in V4B 11.3(86). 
We were surprised to find that these 20 additional vari- 
ants fall into only two selection groups typified by 
V5A13.1(86) and V4Bl 1.3(86). This likely reflects the 
selection process by which the original variants were 
isolated. The V5A13(86) and V4Bl l(86) variants pre- 
sumably represent independent plaque isolates of two 
deletion mutants which were present in the 1986 stock 
of wild-type virus that were selected in the first round 
of neutralization. To determine whether these two de- 
letions represented reproducible as opposed to 
chance events we selected an additional 5A13.5 
variant from a multiply passaged stock derived from 
the 1986 plaque-purified stock of MHV-4 termed 
FIG. 1. Nucleotide and predicted amino acid sequence of the MHV-4 E2 gene. The numbering starts at the ATG codon. Open circles indicate 
the N-terminal signal sequence (calculated according to the algorithm of Von Heijne (1986) as described by Fazakerley and Ross (1989)) and 
closed circles indicate the hydrophobic carboxy-terminal transmembrane domain. Potential glycosylation sites are indicated by boxed aspara- 
gine residues (Neuberger er al., 1972). The intergenic homology sequence TAATCTAAAC is boxed. The putative proteolytic cleavage site 
between the amino-terminal and carboxy-terminal domain is indicated by an arrowhead. The MHV-JHM amino acid sequence (Schmidt et a/., 
1987) is indicated where differences occur. The sequence unique to MHV-4 and deleted from MHV-JHM is marked with asterisks. 
1 
HL?VpILLLPSCLGYIGD?RCIQTVI4YNGN/?jASAPSISTE 40 
A~CTGTTCGTCmATTnACTATTACC~~TGTTTAOGG 120 
oooqooopRooo~oooo 
AVDVSKGLGTYYVLDRVYL~ATLLLTGYYPVDGSNYRNLA 60 
GCMiTCGATG~TC~~TCTGGCCACTTACTATG~TAGATCGTG~A~~~C~CG~ATTG~A~G~A~ATC~TGGACGG~C~~ATCGGMT~CGCG 240 
LTGTNTLSLTW?KPP?LSE?NDG IFAICVQNLKTNTPTGAT 120 
CTTACAGGCACTMTACCTTMGC~ACGTGG~T~C~CCC~~MGTGAG~MTGATGGTATAT~G~~GTCCAGMCCTCMGAC~TACGC~~GTGCMCC 360 
SYFPTIVIGS';FG~T SYTVVLEPYNNIIMASVCTYTI C Q L 160 
TUTATTTTCCCACTATAGTTATA~TAG~TG~TGGTMCA~TC~ATACCGTAG~~ffiAGCCATATMTMTA~ATMTGGCTTCTGTTTGTACATATACCA~GTCM~A 480 
PYTPCKPNTNGNRVIGFWHTDVKPPICLLKR@pTFNVNAP 200 
CCTTACACACCCTGTMGCCACCMTGGTMTCGTMTCGTGTTATTGGATTTTGGCACACAGATGTC~CCGCCGA~GT~~~GCGTMTTTTACGT~MTG~MTGCCCCT 600 
WLYFH?YQQGGTFYAYYADKPSATTFLFSVYIGDI L T  Q Y F' 240 
TGGCTTTATTTCCA~TTTATCAGCAGGGTGGTA~~TTATGCGTACTATGCGGAT~C~TCCGCTA~ACGT~TG~TAGTGTGTATA~GGC~CA~M~~GTATTTT 720 
. A 
VLPFICTPTAGSTLLPLYWVTPLLKRQYLPRPNEKGVITS 280 
GTGTTACCTTTTATTTGTACTCCMCAGCTGGTAGCACT~ACTGCCGCT~ATTGGG~ACACC~TACTTMGCGC~TATTTG~TM~MTG~~TGT~~A~AGT 840 
AVDCASSYISEIKCKTQS LLPSTGVYDLSGYTVQPVGVVY 320 
GCTG~GATTGCGCCAGCAGCCATTAGTGAMTAAMTG~T~TGTMGACC~GTCTCTTACCGAGTA~GGTGT~ATGATffATCCGGTTACACGGTC~C~G~~AG~GTGTAC 960 
RRVPNLPDCKIEEWLTAKSVPSPLNWKRRTPQNCN~RLSS 360 
CGGCGTGTTCCTMCCTACCTGA~GT~TAGAGGMTGG~CA~G~~T~GTGCCGTCACCTCT~~GGGAGCGTAGGA~CC~~GTM~M~MG~GC 10110 
LLRYVQAESLSCRNIDASKVYG~CPGSVSVDK?A~PRSRQ 400 
CN~CTACGTTATGTCCAGGCAGTCTTTGTCGTCGTGTMTMTA~GATGCGTC~GTGTATGGTATGTGC~GGT~TGT~CAG~GAT~~G~ATCCCCCGMGCCGT~ 1200 
*****‘****f****~****‘*****‘**************.*****‘****g*********jt 
CAQPDIVSACTSQTKPMSAYCPTGTIURECSLWNGPKLRS 520 
TGTGCACMCCGOAUTACG~~~AGT~GACC~CCCATGT~G~A~GCCCCA~~CA~~~TCG~~TG~~ CTTTGGMTGGGCCCCAFYTGCGCTCG 1560 
****~*********~****‘****f**********’****~*********~****.* 
ARVGSGTYTCKCTCKPNPFDTYDLRCGQIKTI VNVGDHCC 560 
1600 
****ti*********t*********‘******* *******e*********.* 
GLGVLEDKCGNSDPHKGCSCANDSFIGUSHDTCLVUDRCQ b 
GOTCKiGGTG~AGMGAT~TGTGG~T~CGATCCA~TMGGG~G~~GTGC~T~~~ATC~AT~T~~~~~G~ffiT~~TCG~C~ 
N 
EENPLRYFDSYLGCVVNAD~R TDEALPlCDLRlGAGLCVD 
GAGGAAAACCCCCTTMCTA TTTTGATAGTTAmooQ 
I 
~TOTEG~M~eTGATMCCG~CGGATG~CG~C~M~C~T~CCGTA~TG~~~A~CGT~T 
t- . . . * . . . . . YSKSRRARRSVSTGYRLTTfEPYUPBLVmDSVQ SVGGLYE 
TA~CAMOTCACGUIOMiCCCGCC~T~~~A~G~ATCGA~MC~~~C~C~TA~TGCCGA~~~T~~AT~CG~~TCCGTA~~A~ATA~ 
600 
1800 
640 
1920 
600 
2040 
720 
2160 
760 
2210 
800 
2400 
840 
2520 
080 
2640 
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SSRLPDGISGPIDDIOFS PLLGCIGSTCAEDGAGPSAIRG 920 
AGTTCGAGGCTGCCAGATGGCATCTCCOOCCCTATAOATAGATGACA~M~~GTC~~A~~ATG~TffiG~~~TGTG~~~~~~C~~~CGATAC~ 2760 
RSAIEDLLPDKVKLSDVG?VEAYNmCT GGQEVRDLLCVQS 960 
CGTT~GCTATAGAGGATTTATTAT~GACM~TC~CTATCTGACG~GGC~GTCGAGGC~ATMCM~GCA~GGTGGT~GMG~CGCGAC~CC~GCGTA~T~ 2880 
FNGIKVLPPVLSESQI SGYTAGATAAANFPPWTAAAOVPC 
TTTMTGGCATC~GTATTACCTCCCGTGTTGTCFGhGAGAGTC~TCT~GGCTACACAGCGGGTGCTA~GCGGCAGffATG~CCCAC~~A~G~GCTG~GGTGTGC~~C 
1000 
3000 
1040 
3120 
DATNSALGKIQSVVNANAEALNNLLNQLSNKFGAI SASLQ 1080 
GATGCMCCMTTCTG~CTAGGTMGATCC~TCCGTTG~MTGC~CGCTGMGCA~TMTMT~ATT~C~~~MTAGGTTTGGTGCTATTAGTG~T~~A~ 3240 
EILTRLDAVEAKAQI DRLINGRLTALNAYISKQLS D S T  L I 
GlrhATTCTMCGCGGCTTGACGCTGTAGMGC~GGCCCAGATAGATCGTCTTATTMTGG~GGTTM~GCA~TMTGCGTATATATCCMGCMCT~GTGATAGTACG~A~ 
1120 
3360 
1160 
3480 
GLCFIHP SYVPTSFKTA@VS PGLCISGDRGLAPKAGYFVQ 
GGCTTATGTTTTATTCATTTCAGCTACGTGCCMCATCC~T-CGGC~TGTGAGTC~GGA~ATGCA~TCTGGT~TA~GGA~GGCACCT~GCTGGATA~G~CM 
. A 
DNGEWKFTGSNYYYPEPITDKNSVVHISCAV@YT KAPEVF 
GATMTGGAGAGTGGMGTTCCAGGCffiTM~ATTACTACCCTGMCCCA~A~AT~TAGTG~GT~T~TC~~GCG~GTGMTTACAC-GCGC~G~~TC 
1200 
3600 
1240 
3720 
L@jNSIPNLPDFKEELDKWFKmQT SIAPDLSLDFEKL@VTF 1280 
TTOhACMCPCMTACCAMTCTACCCGA~~MG~GGAG~AGAT~TGG~~MT~GACGT~A~CGCCT~~ATCCCTCGAT~CGAGMG~~TGTTA~C 3840 
LDLTYEt4NRIQDAIKKL~CS YINLKEVGTYEHYVKWPWYV 1320 
CTGGACCTGACFTATGMM~~~~GGATGUUTTM 3960 
WLLIGLAGVAVCVLLF FICCCTGCGSCCFRKCGSC~DEY~ 
TGGTTGCPMTTGGTTTAGCTGGTGT~CCG~GTT 
Na@ee~*NN*ee@aNNeNm*oN@~*eeo 
. 
GHQDSIVIH~ISAHED' 1376 
GGACACCAGGACMjTATTGTGATACATMTA~CAGCCCATGAGGATTGA~ATCA~ 4139 
1360 
4060 
FIG. l-Continued 
V5A13(88). The E2 gene of KiA13(88) was sequenced 
from position 1229 through position 1788 (relative to 
the MHV-4 sequence) and was found to contain a 
unique deletion of 447 nucleotides (nucleotides 1307- 
1753) with the potential to encode a protein with a dele- 
tion 149 amino acids (aa 436-585) representing a 
third selection group. 
A partial sequence for the E2 gene of JHM-X was 
also determined. JHM-X was of interest because the 
virus has recently been shown to have both a smaller 
E2 encoding mRNA and smaller E2 glycoprotein (Ta- 
guchi and Fleming, 1989) than wild-type virus. Partial 
sequence analysis of JHM-X RNA (nucleotides 1208- 
1908, relative to the MHV-4 sequence) localized a dele- 
tion of 458 nucleotides (1336-1794) to the same re- 
gion of the E2 gene that was deleted in the antibody- 
resistant variants of MHV-4. This deletion results in a 
loss of 153 amino acids in E2. Table 1 summarizes the 
size and location of deletions found in the MHV vari- 
ants. 
Comparison of E2 among MHV-4, MHV-JHM, 
MHV-A59, JHM-X, and MHV-4 variants 
Murine coronaviruses display extensive polymor- 
phism in E2 (Talbot and Buchmeier, 1985; Fleming er 
al., 1983). Differences between MHV-A59 and MHV- 
JHM have been mapped to the amino-terminal domain 
of E2, where both substitutions and an 89 amino acid 
sequence unique to MHV-A59 have been described 
(Luytjes et a/., 1987). This additional stretch of 89 
amino acids in MHV-A59 was located in the same area 
of the E2 protein where we have identified deletions in 
variants derived from MHV-4. To clarify the relation- 
ships in terms of heterogeneity of E2, in Fig. 3 we have 
compared the predicted amino acid sequences from 
the amino-terminal domain (amino acids 415-608 rela- 
5’ 
T 
A 
2 
T 
TG 
A 
T 
C 
: 
G 
MHV-4 V5A13.1(86) V4611.3(86) 
TCGA TCGA TCGA 
FIG. 2. Nucleotide sequence analysis from the relevant regions of sequencing gels comparing wild-type MHV4, V5A13.1(86), and 
V4B11.3(86). The sequence shown for MHV-4 represents nucleotides 169991777. Sequences were determined using the chain terminating 
dideoxy sequencing procedure as described. Lanes are labeled T, C, G, and A for the appropriate chain terminating dideoxynucleotide. Arrows 
indicate the position of the deletions with the nucleotide sequence flanking the deletions shown. 
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tive to the MHV-4 sequence) for several strains of 
MHV. MHV-4 and MHV-A59 contain a run of relatively 
conserved amino acids (90% homology) beginning at 
position 454 (454-500 and 553-594 relative to the 
MHV-4 sequence) that are not found in JHM. In addi- 
tion, MHV-4 contains an additional stretch of 52 unique 
amino acids starting at position 501 that are not found 
in A59. 
DISCUSSION 
In this study we have analyzed the E2 gene of wild- 
type MHV-4 and of three independently selected MAb- 
resistant variants V4B 1 1.3(86), V5A13.1(86), and 
V5A13(88). By direct RNA sequencing all three variants 
were found to have deletions of 426 to 477 nucleotides 
localized to the 5’ coding region of the gene (nucleo- 
tides 1285 through 1761 of the parental E2 sequence; 
Fig. 1). The variant E2 genes have the potential to en- 
code truncated E2 proteins with deletions in the amino- 
terminal region ranging from 142 amino acids in the 
case of V5A13.1(86) to 159 amino acids in the case of 
V4Bl 1.3(86) (Table 1). These results confirm and ex- 
tend previous analyses of viral RNA and protein (Gal- 
lagher et a/., submitted for publication) which demon- 
strate deletions in the amino-terminal cleavage product 
of E2. 
The sequence of the E2 gene of MHV-4 was nearly 
identical to that of MHV-JHM reported by Schmidt eta/. 
(1987) with the notable exception that MHV-4 has an 
additional 423 nucleotides in the coding region of E2 
(Fig. 1). The E2 gene of our MHV4 strain potentially 
encodes a larger protein than JHM (1376 amino acids 
as compared to the 1235 amino acids of MHV-JHM) 
with a unique stretch of 141 amino acids in the amino- 
terminal domain of E2. These data clearly demonstrate 
that MHV-JHM and MHV-4, which were previously con- 
sidered interchangable, are in fact distinct viruses. 
Given the otherwise near identity between the E2 
genes of the two viruses and the relative ease of selec- 
tion of deletion mutants, it might be speculated that 
MHV-JHM arose as a deletion mutant of MHV-4. 
It was previously observed that the selection for MAb 
resistance to epitope E2B also resulted in resistance 
to epitope E2C and the reciprocal was true for selec- 
tion of MAb resistance to epitope E2C (Dalziel et al., 
1986). This acquisition of resistance to multiple epi- 
topes can now most easily be reconciled by the se- 
quence data showing that the antibody-resistant vari- 
ants have large overlapping deletions which presum- 
ably result in the loss of both epitopes. While we cannot 
ignore the possibility that these deletions affect protein 
folding and conformation at distant sites, it appears 
clear that the deleted sequence contains determinants 
critical for the structure of both epitopes. 
TABLE 1 
Variant Nucleotide deletion 
V5A13.1 (86) 426(1298-1723) 
V4B11.3 (86) 477 (1285-1761) 
V5A13 (88) 447 (1307-l 753) 
JHM-X 458(1336-1794) 
Amino acid deletion 
142(434-575) 
159(429-586) 
149 (436-585) 
153 (446-598) 
It is interesting to note that although V5A13.1(86) 
and V5A13(88) were selected by the same MAb, these 
variants contain unique deletions (Table 1). V5A13.1(86) 
was isolated from a minimally passaged stock of MHV- 
4 and the E2 sequence of this variant represents the 
sequence of an individual plaque-purified isolate. In 
contrast, V5A13(88) was isolated from a stock of MHV- 
4 which had been passed multiple times in vitro. As 
V5A13(88) was not plaque purified, the E2 sequence 
for this variant represents the predominant sequence 
of the population of antibody-resistant variants present 
in the multiply passaged stock of MHV-4. 
The deletions we have observed all map to a hydro- 
philic domain in the amino-terminal half (aa 429-598) 
of E2 (Fig. 3) indicating that neutralization epitopes and 
determinants associated with neurovirulence map to 
this region of the protein. This is in contrast to a previ- 
ous study where neutralization epitopes and neuroviru- 
lence determinants were mapped to the carboxy-termi- 
nal domain of E2 using recombinants between MHV- 
JHM and a ts mutant of MHV-A59 (Makino eta/., 1987). 
Recombinants which had lost the MHV-JHM neutraliz- 
ing epitopes defined by MAbs J7.2 and J2.2 were ana- 
lyzed by T, oligonucleotide fingerprinting and the 
crossover site in these recombinants was localized to 
a region 1.5 kb from the 3’ end of the E2 gene; thus, 
it was concluded that these epitopes mapped to the 
carboxy-terminal domain of the protein. However, 
MAbs J7.2 and J2.2 react ,with our wild-type MHV-4 but 
fail to react with any of our antibody-resistant variants 
(Dalziel et al., 1986) nor do they react with JHM-X (Ta- 
guchi and Fleming, 1989). Our variants and JHM-X all 
have large deletions in the amino-terminal half of E2. 
These data strongly suggest that MAbs J7.2 and J2.2 
detect epitopes in the amino-terminal and not the car- 
boxy-terminal domain of E2. This apparent discrepancy 
in mapping of epitopes recognized by MAbs J7.2 and 
J2.2 could most easily be reconciled if both recombina- 
tion and deletion occurred in the cells coinfected with 
MHV-A59 and MHV-JHM. Alternatively, the A59-JHM 
recombinant viruses may have arisen as a result of a 
recombination between MHV-A59 and E2 deletion 
variants preexisting in the MHV-JHM parent popula- 
tion. 
MHV-4 
VSA13.1(86) 
V4811.3(86) 
V5Al3(88) 
KIDTMTSCQLYYSLPXElHI~YNPSSWNRRYGFNDAGVFG~~DVAYAQQCF~PSYCPCAQPDIVSACTSQTK~SAYC~GTIHRE 
NYKIDTAATSCQLYYSLZfj . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
NYKIDTMTSCQLY................................................................................. 
NYXIDTMTSCQLYYSLPKNN.......................................................................... 
NliV-A59 
WHV-JHW NYKIDTMTSCPLYYSLPKNNINNYNPSSWNRRYG~ ........................................................ 
JHM-X NYXIDTMTSCQLYYSLINNYNPSS ................................................................ 
Signal 
POLYMORPHISM AND DELETIONS IN E2 671 
Cleavaae Transmembrane 
CSLWNGPHLRS~VGSGTYTCECTCKPNPFDTYDLRCGQI~I~GDHCEG~VLEDKCGNSDPRKGCSCMDSFIGWSH~CL~DRCQIF~I~ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..KGCSCMDSFIGWSHDTCLVNDRCQIF~IL~ A 142 aa 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..GWSN~CL~DR~IF~IL~ A 159 aa 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IGWSWDTCLVNDRCQIFANILLN A 149 aa 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..YNVCDHCEG~VLECBCG~PHKG~~FIGWSH~CL~DRCQIF~IL~ A 52 LIa 
................................................................................... ..~DRCQIF~IL . A 141 aa 
....................................................................................... ..~IF~IL . A 153 aa 
FIG. 3. Hydropathicity plot of the MHV4 E2 glycoprotein according to the analysis of Kyte and Doolittle (1982) and localization of the deletions 
in the amino-terminal domain of MHV-4 E2. The vertical scale is the average hydropathicity (+2 to -2) index for each residue over a window of 
9 amino acids. Hydrophobic sequences appear above the midline and hydrophilic sequences appear below the midline. Below is an alignment 
of amino acid residues 415 through 608 from MHV-4 E2 with the comparable amino acid sequences from MHV-JHM (Schmidt et al., 1987) 
MHVA59 (Luytjes era/., 1987) JHM-X, and MHV-4 variants V8A13.1(86), V4B11.3(86), and V5A13(88), all determined in this laboratory. Dots 
indicate deletions and boxed amino acids indicate sequence changes from MHV-4 E2. The signal sequence, putative cleavage site, and trans- 
membrane domains of E2 are indicated. 
We have found that the E2 protein of MHV-4 is very 
heterogeneous with respect to deletions in the amino- 
terminal domain (Fig. 3). Heterogeneity in terms of the 
size of the E2 gene has also been reported to result 
from both the in vivo and in vitro passage of MHV-JHM. 
Taguchi eta/. have reported isolation of.variants of JHM 
from the brains of rats and from primary rat neuronal 
cultures with a larger E2 (ca. 15 kDa) than that of the 
parental IHM wild-type (Taguchi et al,,, 1985, 1986). In 
contrast, Morris et al, (1989) have isolated a variant 
from the spinal cord of MHV-JHM infected rats which 
had a smaller E2 than the wild-type strain used to inoc- 
ulate the animals. It will be of interest to determine 
whether these differences represent insertions or dele- 
tions of the polymorphic sequences we have de- 
scribed. 
The mechanism of generation of diversity in E2 re- 
mains an open question. It has been suggested that 
genetic diversity among murine coronaviruses arises 
as a result of high-frequency RNA-RNA recombination 
between heterologous strains (Lai et al., 1985; Makino 
et al., 1986; Keck et al., 1988) and even between coro- 
naviruses and other enveloped RNA viruses (Luytjes et 
a/., 1988). Recombination is proposed to occur as a 
consequence of the discontinuous, nonprocessive 
mechanism of transcription involved in MHV replica- 
tion. According to this model, RNA synthesis frequently 
stops at sites of secondary structure on template RNA 
releasing the transcriptional com:plex which then. re- 
joins the template RNA and resumes transcription 
(Baric et al., 1987). This process involving a jumping 
polymerase may also result in deletions whereby the 
disassociated transcriptional complex reinitiates and 
resumes transcription at a distant site on the same 
template or on a sister strand. If this transfer involves 
RNA base pairing, one might expect to find homolo- 
gous sequences flanking the deletion sites that would 
provide site specificity for the nascent RNA strand. 
However, we were unable to find any homologous or 
consensus sequences flanking the deletions in the E2 
gene (Table 2). In addition, a computer analysis of the 
nucleotide sequence of E2 did not reveal any unique 
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TABLE 2 
NUCLEOTIDE SEQUENCE OF MHV4 IN REGIONS FLANKING DELETIONS IN E2 
Virus 5’Flanking sequence 3’ Flanking sequence 
V5A13.1 (86) 
V5A13 (88) 
V4B11.3 (86) 
MHV-JHM 
JHM-X 
a 
4 
AGTCTTCCTAAGAATAATGT. 
c 
AAGAATAATGTTACCATAAA. 
+ 
TCAGCTGTATTACAGCTTCC. 
4 
ATGGTTTTAATGATGCTGGT. 
t 
CCCCTCGTCTTGGAATAGGT 
b 
4 
AGCGATCCACATAAGGGCTG 
4 
AATGATTCTTTTATCGGATG 
4 
TTTTATCGGATGGTCACATG 
4 
ACACTTGTTTAGTAAATGAT 
4 
AAATGATCGCTGCAAATTTT 
a 5’ Endpoint of deletion. 
b3’ Endpoint of deletion. 
sites of secondary structure in the polymorphic region 
of the gene. Equivalent regions of predicted secondary 
structure were found throughout the entire gene (data 
not shown). Thus perhaps deletions occur randomly 
throughout the genome during replication but dele- 
tions in most regions may be lethal. It appears clear 
that the amino-terminal domain of E2 can accommo- 
date large deletions while retaining functions neces- 
sary for growth in vitro. In contrast, viable recombina- 
tion in other genes or in other sites on E2 may require 
site-specific recombination to occur without the ac- 
companying loss of genetic information. 
We have localized an area in the amino-terminal re- 
gion of the E2 glycoprotein of MHV-4 which is highly 
heterogeneous and subject to deletion mutation. De- 
terminants localized within this region, while dispens- 
able for in vitro growth and replication, play an impor- 
tant role in determining the outcome of an in vivo infec- 
tion. This could be reflected at the level of receptor 
binding and hence determine the tissue tropism of the 
virus or at the level of events occurring during the repli- 
cation and maturation of the virus and hence determine 
the ability of the virus to amplify and spread. We are 
presently pursuing the functional significance of this 
domain of the MHV-4 E2 in order to evaluate its role in 
tissue tropism and pathogenesis in vivo. 
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